Chronic Hepatitis C
HEPATITIS C --- Navigation Topics
• Top New Articles on HCV
• All HCV Articles by Topic ( A to Z )
• HCV Basics
• HIV-HCV Coinfection
• FDA-approved Treatments for HCV
- Roferon A (interferon alfa-2a)
- Intron A (interferon alfa-2b)
- Infergen (consensus interferon)
- Pegasys (peginterferon alfa-2a)
- PegIntron (peginterferon alfa-2b)
- Copegus / Rebetol (ribavirin)
- Intron A + Rebetol
- Roferon A + Ribavirin
- Pegasys + Copegus
- PegIntron + Rebetol
• Treatment Guidelines for HCV
• Experimental Treatments for HCV
• Recent Research Conference Reports
• Tests for HCV
• Liver-related Complications
• Drug-related Adverse Events
• Doctor Is In 'Q and A' for HCV
• Library of CME Programs
• E-mail Update - Sign Up
• About Us - Contact Us
_______________
Growth Factors:
erythropoietin / G-CSF / filgrastim
Blood Cell
Growth Factors
Improve Adherence and SVR Rates
- 6/06/06
Suppression of Blood Cell Formation during Chronic Hepatitis C Therapy with Different Interferon Alfa Mono- and Combination Therapy Regimens
- 7/15/05
Filgrastim for the Neutropenia Associated with Combination Therapy in Chronic Hepatitis C
- 6/01/05
The Effect of
Hematological Growth Factors
on the Rate of Sustained Viral Response (SVR) in Chronic Hepatitis C
- 5/23/05
High Early Virologic Response in Patients with Chronic HCV Genotype 1 Treated with Peginterferon Alfa-2b (PegIntron) and Ribavirin: The Impact of
Growth Factors
- 4/20/05
Treatment of Established Recurrent Hepatitis C in Liver Transplant Recipients with Pegylated Interferon Alfa-2b and Ribavirin Therapy
- 1/14/05
Role of
Growth Factors
in the Treatment of Patients with HIV-HCV Coinfection and Patients with Recurrent Hepatitis C After Liver Transplantation
- 1/12/05
HIV AND AIDS
|
HEPATITIS B
|
HEPATITIS C
|
HIV / HBV CO-INFECTION
|
HIV / HCV CO-INFECTION
|
HEALTH AND TECHNOLOGY
|
TESTS
|
INTERNET CONFERENCE REPORTS
|
TELECONFERENCES
|
LINKS
|
ABOUT US
|
CONTACT US
